Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Watanuki, N. Miyazawa, M. Kudo, S. Inoue, H. Goto, T. Kaneko, H. Takahashi, Y. Ishigatsubo (Yokohama, Japan). Effects of pneumococcal vaccine in patients with chronic respiratory disease. Eur Respir J 2007; 30: Suppl. 51, 1368

Member's Comments

No comment yet.

Related content which might interest you: Analysis of efficiency of joint or consistent vaccination with pneumococcal and influenzal vaccines in patients with chronic obstructive pulmonary disease Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Effectiveness of polysaccharide pneumococcal vaccination among subjects with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 442s Year: 2006 No preventive effects of 23-valent pneumococcal polysaccharide vaccine in patients with chronic renal failure Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Inhalative vaccination with pneumococcal polysaccharide in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 372s Year: 2007 Results of vaccination against pneumococcal infection in patients with chronic lung diseases Source: International Congress 2019 – Airway infection in COPD Year: 2019 Effectiveness of 23-valent pneumococcal polysaccharide vaccine in preventing lower respiratory tract infections complicating chronic respiratory failure Source: Eur Respir J 2006; 28: Suppl. 50, 576s Year: 2006 Results of vaccination against pneumococcal infection in patients with chronic heart failure Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020 Influenza and pneumococcal vaccines prevalence and their influance on asthma and chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 292s Year: 2005 Pneumococcal vaccination in chronic respiratory patients – a cohort study Source: International Congress 2019 – Airway infection in COPD Year: 2019 Prophylactic efficacy of pneumococcal vaccination for chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 178s Year: 2006 Analysis of the Effect of pneumococcal vaccination in patients with COPD in combination with bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Efficacy of influenza and pneumococcal vaccinations among patients with COPD Source: Annual Congress 2007 - Treatment of COPD Year: 2007 Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Impaired response to 13-valent pneumococcal conjugate vaccine (PCV13) in children with recurrent respiratory infections and chronic cough. Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021 Influenza and pneumococcal vaccination in patients with COPD Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Effect of vaccination of pneumococcal infection on the course of chronic obstructive pulmonary disease in combination with diabetes mellitus Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes Year: 2019 Chronic pulmonary diseases and the epidemiology of invasive pneumococcal infection Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Clinical effect of different pneumococcal vaccination schedules in patients with chronic obstructive pulmonary disease (COPD): long-term follow-up results Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017